• Publications
  • Influence
Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients.
OBJECTIVES To determine the efficacy of prophylactic ciprofloxacin in preventing urinary tract infections caused by urodynamic study (UDS). METHODS A total of 210 patients presenting for UDS duringExpand
  • 37
  • 4
Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Combined treatment with pegylated interferon (PEG-IFN) and ribavirin is currently recommended for the treatment of chronic hepatitis C virus (HCV) infection. Many side effects including hairExpand
  • 35
  • 3
Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment
This retrospective study was performed in two university hospitals between January 2002 and 2006. Ninety-nine brucellosis patients were included in the study. These patients were classified as acuteExpand
  • 22
  • 3
The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors.
OBJECTIVE To determine the prevalence of extended-spectrum beta-lactamase (ESBL) producing Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli), risk factors of ESBL-producing strainsExpand
  • 28
  • 2
[Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents].
Nosocomial urinary tract infections (NUTI) which are usually in the first rank in health care associated infections, significantly influence mortality, morbidity, hospitalization period and cost. InExpand
  • 8
  • 2
Several Cytokines and Protein C Levels with the Apache II Scoring System for Evaluation of Patients with Sepsis.
OBJECTIVE We investigated whether determination IL-6, IL-8, IL-1beta and TNF-alpha at baseline, total protein C (PC) levels at time of admission and 48 hours after initiation could complement theExpand
  • 4
  • 1
  • PDF
Exacerbation of Psoriasis due to Peginterferon alpha-2b plus Ribavirin Treatment of Chronic Active Hepatitis C
A 45-year-old woman with chronic hepatitis C was treated with peginterferon alpha-2b in combination with ribavirin, which activated psoriasis. In the patient, psoriasis reoccurred after beingExpand
  • 37
Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B
The aim of this study was to assess morbidity and the incidence of adverse effects during interferon (IFN)-α-2a treatment of patients with chronic hepatitis B. This prospective study included 48Expand
  • 13
Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study
BACKGROUND Knowing risk factors for colistin resistance is important since colistin is the only remaining choice for the treatment of infections caused by multi-drug resistant microorganisms.Expand
  • 12
  • PDF
Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B.
The aim of this study was to assess morbidity and the incidence of adverse effects during interferon (IFN)-alpha-2a treatment of patients with chronic hepatitis B. This prospective study included 48Expand
  • 14
...
1
2
3
4
5
...